162 related articles for article (PubMed ID: 37748497)
21. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
22. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
Galappaththy GN; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
[TBL] [Abstract][Full Text] [Related]
23. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
24. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
Hossain MS; Commons RJ; Douglas NM; Thriemer K; Alemayehu BH; Amaratunga C; Anvikar AR; Ashley EA; Asih PBS; Carrara VI; Lon C; D'Alessandro U; Davis TME; Dondorp AM; Edstein MD; Fairhurst RM; Ferreira MU; Hwang J; Janssens B; Karunajeewa H; Kiechel JR; Ladeia-Andrade S; Laman M; Mayxay M; McGready R; Moore BR; Mueller I; Newton PN; Thuy-Nhien NT; Noedl H; Nosten F; Phyo AP; Poespoprodjo JR; Saunders DL; Smithuis F; Spring MD; Stepniewska K; Suon S; Suputtamongkol Y; Syafruddin D; Tran HT; Valecha N; Van Herp M; Van Vugt M; White NJ; Guerin PJ; Simpson JA; Price RN
PLoS Med; 2020 Nov; 17(11):e1003393. PubMed ID: 33211712
[TBL] [Abstract][Full Text] [Related]
25. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
26. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Sinclair D; Gogtay N; Brand F; Olliaro P
Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
[TBL] [Abstract][Full Text] [Related]
27. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Sutanto I; Soebandrio A; Ekawati LL; Chand K; Noviyanti R; Satyagraha AW; Subekti D; Santy YW; Crenna-Darusallam C; Instiaty I; Budiman W; Prasetya CB; Lardo S; Elyazar I; Duparc S; Cedar E; Rolfe K; Fernando D; Berni A; Jones S; Kleim JP; Fletcher K; Sharma H; Martin A; Taylor M; Goyal N; Green JA; Tan LK; Baird JK
Lancet Infect Dis; 2023 Oct; 23(10):1153-1163. PubMed ID: 37236221
[TBL] [Abstract][Full Text] [Related]
28. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
Pasaribu AP; Chokejindachai W; Sirivichayakul C; Tanomsing N; Chavez I; Tjitra E; Pasaribu S; Imwong M; White NJ; Dondorp AM
J Infect Dis; 2013 Dec; 208(11):1906-13. PubMed ID: 23926329
[TBL] [Abstract][Full Text] [Related]
30. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Pryce J; Hine P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD006404. PubMed ID: 30620055
[TBL] [Abstract][Full Text] [Related]
31. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
[TBL] [Abstract][Full Text] [Related]
32. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
33. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
[TBL] [Abstract][Full Text] [Related]
34. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Mwaiswelo R; Ngasala BE; Jovel I; Gosling R; Premji Z; Poirot E; Mmbando BP; Björkman A; Mårtensson A
Malar J; 2016 Jun; 15():316. PubMed ID: 27287612
[TBL] [Abstract][Full Text] [Related]
35. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
[TBL] [Abstract][Full Text] [Related]
36. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
IMPROV Study Group
BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
[TBL] [Abstract][Full Text] [Related]
37. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
38. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
39. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
40. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
